| 摘要 |
The present invention relates to (E,E)-6,10,14-trimethyl-5,9,13-pentadecatrien-2-one for its application as a therapeutically active substance. It has been demonstrated that this compound exhibits a specific activity towards tumours, which is capable of being applied in therapeutics.
|
